| Document |
Document Title |
|
WO/2011/099584A1 |
Disclosed is an ethylene homopolymer or an ethylene and an α-olefin copolymer catalyst which includes a complex represented by formula (1). (In the formula: n is 2 or 3; R1 and R2 are independently an optionally substituted alkyl group ...
|
|
WO/2011/098417A1 |
Substituted cyanobutyrates of the formula I in which the variables are defined according to the description, processes and intermediates for preparing the compounds of the formula I and their N-oxides, their agriculturally suitable salts...
|
|
WO/2011/099583A1 |
Disclosed is a stereoselective olefin polymerization catalyst which includes a complex represented by formula (1). (In the formula: n is 2 or 3; R1 and R2 are independently an optionally substituted alkyl group or a halogen atom; L is a ...
|
|
WO/2011/096370A1 |
Disclosed is a curable fluorinated resin composition that exhibits superior heat stability and thermal adhesion characteristics. Specifically disclosed is a curable fluorinated resin composition comprising a thiol compound (S) and a fluo...
|
|
WO/2011/097092A2 |
The present invention provides for compounds of Formulas I-III, and salts thereof, wherein n, m, R, 1, R, R, and 1 τ R-) 4 have any of the values defined there for in the specification. The compounds of formula I may be used in the synt...
|
|
WO/2011/093497A1 |
Provided is a plasma oxidation-reduction method with which it is possible to control the structure of amino acids and proteins with high and stable reproducibility, by using plasma in order to control the amino acids and proteins that ma...
|
|
WO/2011/087717A1 |
Fluorinated arylene-containing compounds and fluorinated polymers formed from fluorinated arylene-containing compounds, and methods are described. Fluorinated polymers formed from fluorinated arylene-containing compound can be used to pr...
|
|
WO/2011/088015A1 |
Compounds of formula (I) are disclosed. Compounds according to the invention bind to and are agonists, antagonists or inverse agonists of the CB2 receptor, and are useful for treating inflammation. Those compounds which are agonists are ...
|
|
WO/2011/082488A1 |
This invention provides compounds having a structure of Formula (I). Uses of such compounds for treatment of various indications, including prostate cancer as well as methods of treatment involving such compounds are also provided.
|
|
WO/2011/085033A2 |
Described herein is the DP2 anatgonist 2-(3-(2-((tert-butylthio)methyl)-4-(2,2-dimethyl- propionylamino)phenoxy)-4-methoxyphenyl)acetic acid, or a pharmaceutically acceptable salt thereof. Also described are methods of preparing the DP2 ...
|
|
WO/2011/083254A1 |
The invention relates to a method for preparing acrolein from glycerol or glycerine, according to which the glycerol or glycerine is dehydrated in the presence of a catalyst that consists of least one silica modified by zirconium dioxide...
|
|
WO/2011/080648A1 |
The present invention relates to an improved process for the preparation of Cilastatin Sodium of formula (I), having mesityl oxide content less than 2000 ppm and more than 1 ppm. (Formula I) (I)
|
|
WO/2011/074815A2 |
The present invention relates to a method for preparing N,N'-dialkyl-3,3'-dithiodipropionamides which are intermediate compounds used for preparing substituted 3-isothiazolones. More particularly, the method of the present invention comp...
|
|
WO/2011/073143A1 |
Substituted cyanobutyrates of the formula I in which the variables are defined according to the description, processes and intermediates for preparing the compounds of the formula I and their N-oxides, their agriculturally suitable salts...
|
|
WO/2011/070028A1 |
Whilst methodologies for the Kinetic Resolution of alcohols are well established, no analogous direct methods exist for the highly selective, direct catalytic Kinetic Resolution of thiols (i.e., R-SH). The present invention relates to a ...
|
|
WO/2011/069143A1 |
The present invention provides bis-organosulfur compounds of formulae (I) and (II) and compositions comprising the compounds that are effective against animal pests, including parasites. The compounds and compositions may be used for com...
|
|
WO/2011/066115A2 |
An overbased, sulfurized salt of at least one alkylated hydroxyaromatic compound, wherein the alkyl substituent of the hydroxyaromatic compound is a residue of at least one isomerized olefin having from about 15 to about 99 wt. % branchi...
|
|
WO/2011/058915A1 |
Disclosed is a process for producing a high-purity aromatic sulfonyl chloride compound readily, on an industrial scale, and with high efficiency. A reaction product produced by reacting sulfuryl chloride, N,N-dimethylformamide and sulfur...
|
|
WO/2011/046597A2 |
A method is provided for the parallel identification of one or more metabolite species within a biological sample. The method comprises analyzing the sample to produce a spectrum containing individual spectral peaks representative of the...
|
|
WO/2011/045536A1 |
The present invention relates to a method for preparing a polyol having the following general formula (I): said method including a step of transesterification followed by a step of thiolation. The present invention also relates to polyol...
|
|
WO/2011/042288A1 |
The present invention relates to a material including a (poly)glycerol group and a hydrophobic group connected together by a heteroatom, to a method for synthesizing same, and to the use thereof as a surfactant. The present invention als...
|
|
WO/2011/040131A1 |
3-Mercapto-1-propanol can be produced in high yield without using pyrophoric aluminum lithium hydride, by subjecting a compound of the following formula (1) to addition reaction with allyl alcohol to prepare a compound of the following f...
|
|
WO/2011/022805A1 |
The invention relates to colchicine derivatives, methods and uses thereof for treatment of cancer. In certain embodiments, the colchicine derivative comprises a compound of formula (I), wherein Z is O or S; R1 is selected fro H, a halo g...
|
|
WO/2011/023667A1 |
The present invention relates to the use of a compound of general formula (I) wherein R1/R2 are independently from each other hydrogen, lower alkyl, -CH2)o-cycloalkyl for o being 0 or 1, or are benzyl or heterocycloalkyl; or R1 and R2 ar...
|
|
WO/2011/021522A1 |
Provided is a curable composition which can yield a cured product that exhibits a reduced moisture absorption and an enhanced bond strength to a member to be connected. Also provided is a novel (meth)acrylate compound containing a thiol ...
|
|
WO/2011/019076A1 |
A process for the preparation of (fluoroalkylthio)acetic acid esters represented by general formula (3) (wherein R is a hydrogen atom or a C1-5 alkyl group; R1 is a C1-4 alkyl group; and R2 is a C1-5 fluoroalkyl group), characterized by ...
|
|
WO/2011/016605A1 |
The present invention relates to DTPA derivatives capable of forming complexes by combining with metals and the like, metal complexes formed by combining with the DTPA derivatives, MR and CT contrast agents including gold nano-particles ...
|
|
WO/2011/012247A1 |
Described are 2-(3-alkylthiobenzoyl)cyclohexanediones of the general formula (I) as herbicides. X, Y, R1 to R8 in this formula (I) stand for radicals such as hydrogen or organic radicals such as alkyl and alkoxy.
|
|
WO/2011/013307A1 |
Provided are trifluoromethylthiophenium derivative salts useful as intermediates in the synthesis of drugs or agricultural chemicals, a process for production of the same, and a process for the production of trifluoromethyl-containing co...
|
|
WO/2011/002339A2 |
The invention relates to peptide mimetics, more specifically to pharmaceutically acceptable salts of (S)-N-[4-(1-adamantyl)benzoyl]-α-amino acids of the general formula (1), where A+ is an ion of an alkali metal, ammonium and N+(C1-4alk...
|
|
WO/2010/150847A1 |
Disclosed are a dehydroabietic acid polymer having a repeating unit comprising a dehydroabietic acid skeleton derived from dehydroabietic acid and a composite material containing the polymer.
|
|
WO/2010/148488A1 |
The present invention relates to compounds capable of inhibiting and/or decreasing the activity of one or more cathepsins, thereby treating and/or preventing various disease states associated with one or more cysteine proteases including...
|
|
WO/2010/149888A1 |
Compounds of formula (I) in which: R1 represents a hydrogen atom or a group of formula COR4, or else R1 represents a group of formula (A); R2 represents a group of formula NR5R6, or else R2 represents a nitrogen-containing heterocyclic, ...
|
|
WO/2010/141396A1 |
Novel benzoxazine - thiol adducts are described, which may be may be cured to produce compositions useful in coating, sealants, adhesive and many other applications.
|
|
WO/2010/138670A2 |
Disclosed herein are thiocolchicine derivatives suitable for use as muscle relaxants, methods of making the derivatives, and compositions comprising the derivatives.
|
|
WO/2010/133077A1 |
A kind of ketoxime ester compound used as photoinitiator, especially a kind of ketoxime ester photoinitiator used as the photocuring material, wherein said ketoxime ester photoinitiator has following general formula (I): Wherein R1 is fo...
|
|
WO/2010/131962A2 |
The present invention concerns new thiolysine and selenolysine compounds that can be used as building blocks for peptides and proteins, providing ligation handles for site-and chemoselective modification of said peptides and proteins. In...
|
|
WO/2010/127786A1 |
The invention relates to a method for producing oxindoles and ortho-substituted anilines and the use thereof as intermediate products for syntheses. Method for producing compounds of the formula (4): wherein a mixture of an aniline (comp...
|
|
WO/2010/125068A2 |
Imaging agents that comprise labeled substrates of the cystine/glutamate antiporter of cells, whereby the methods of use comprise introducing the labeled agents into cells via the cystine/glutamate antiporter, which are then reduced to a...
|
|
WO/2010/122968A1 |
Disclosed is a compound useful as an anti-obesity agent. Studies have been made on compounds which have a DGAT1 inhibitory activity and are therefore promising active ingredients for pharmaceutical compositions for treating obesity, type...
|
|
WO/2010/117258A1 |
A method of producing an amide ester derivative of azelaic acid comprising treating an amino acid hydrohalide of the general formula (I): wherein R' is a substituted or unsubstituted alkyl, and R" is a substituted or unsubstituted side c...
|
|
WO/2010/115945A1 |
The present invention relates to a compound of the general formula (I) where: X = S, SO or SO2; and one of the radicals R1 and R2 is a hydrogen atom and the other is a radical: a C1 to C18 linear or branched alkyl, optionally substituted...
|
|
WO/2010/116342A2 |
The present invention concerns compounds of general Formula (I) : method of preparation and uses thereof.
|
|
WO/2010/108210A1 |
The invention provides compound which is an 18F-radiolabelled S-propylhomocysteine or a derivative thereof. The compound has an enantiomeric purity of at least about 90%. 18F- radiolabelled S-propylhomocysteine may be made by treating an...
|
|
WO/2010/103429A1 |
The present invention is directed to novel 1,1 -(dimethyl-ethylamino)-2- hydroxy-propoxy]-ethyl}-3-methyl-biphenyl-4-carboxylic acid derivatives and pharmaceutically acceptable salts thereof of structural formula I wherein the variable R...
|
|
WO/2010/100486A2 |
The present invention is directed to a process for the preparation of ajoene, and to ajoene having a relatively high purity which may be obtained by the process. The invention also relates to processes for the preparation of allicin, to ...
|
|
WO/2010/098251A1 |
Provided is a novel loxoprofen derivative represented by formula (I) or (II), or a pharmacologically acceptable salt thereof, which avoids side effects such as gastrointestinal disorders and also has excellent antiinflammatory and analge...
|
|
WO/2010/098372A1 |
A heterocyclic compound represented by formula (1) and a field effect transistor having a semiconductor layer comprising the compound. (In the formula, X1 and X2 each independently represents a sulfur atom or a selenium atom, and R1 and ...
|
|
WO/2010/095745A1 |
Provided is a method that enables 3-mercaptocarboxylic acid, which is industrially useful, to be obtained at high yield with good productivity while limiting the production of by-products, and that additionally has low environmental impa...
|
|
WO/2010/094289A1 |
The present invention relates to allosteric binding compounds of formula (I), especially for the treatment of CNS disorders, together with pharmaceutical compositions and methods of treatment including these compounds.
|
